Rabbit anti-human-T-lymphocyte globulin-less is more

Affiliations

¹ Pediatric Blood and Marrow Transplantation Program, University Medical Center Utrecht, Utrecht, 3512 EA, Netherlands. Electronic address: j.j.boelens@umcutrecht.nl.

Comment

Jaap Jan Boelens. Lancet Oncol. 2017 Aug.

. 2017 Aug;18(8):996-997.

doi: 10.1016/S1470-2045(17)30443-6. Epub 2017 Jul 10.

¹ Pediatric Blood and Marrow Transplantation Program, University Medical Center Utrecht, Utrecht, 3512 EA, Netherlands. Electronic address: j.j.boelens@umcutrecht.nl.

No abstract available

Comment on

Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial.
Locatelli F, Bernardo ME, Bertaina A, Rognoni C, Comoli P, Rovelli A, Pession A, Fagioli F, Favre C, Lanino E, Giorgiani G, Merli P, Pagliara D, Prete A, Zecca M. Locatelli F, et al. Lancet Oncol. 2017 Aug;18(8):1126-1136. doi: 10.1016/S1470-2045(17)30417-5. Epub 2017 Jul 10. Lancet Oncol. 2017. PMID: 28705454 Clinical Trial.